The promise and harms of screening for plasma cell dyscrasias

Abstract

In this perspective, we highlight both the promise and harms of screening for plasma cell dyscrasias, as well as the implications of the use of mass spectrometry for diagnosing monoclonal gammopathy of undetermined significance in routine practice.

Keywords: mass spectrometry; monoclonal gammopathy; multiple myeloma; plasma cell dyscrasia; screening.